![]()
|
|
||||||||
(Received for publication, March 22, 1995; and in revised form, July 13, 1995) The human coagulation protease factor VII plays a pivotal role
in the initiation of the coagulation cascade by both the extrinsic and
the intrinsic pathway. Although the gene, encoding factor VII, is
expressed predominantly in the liver, the mechanisms underlying this
tissue-specific expression have not been elucidated. In this study, we
have analyzed the contribution of 5 kilobases upstream of the ATG
translational initiation codon upon hepatic factor VII gene
transcription. Transient transfection assays of a set of nested
deletions in both liver and non-liver cell lines, HepG2 and HeLa
respectively, indicate that several regions are involved in
liver-specific expression. A slight negative effect on factor VII
promoter activity in HepG2 cells is mediated by sequences upstream of
position -1212. DNase I protection experiments reveal six
footprints, FPVII1 through FPVII6, within the proximal 714 base pairs
but a minimal promoter of 165 base pairs containing only FPVII3-6
is sufficient to confer liver-specific expression in HepG2 cells.
Interestingly, FPVII6, at position -14 to +10 on the sense
strand, would indicate that an as yet unknown transcription factor
covers the ATG translational initiation codon. Gel retardation
experiments show that the liver-enriched transcription factor HNF-4
binds specifically to footprint FPVII4 at position -71 to
-49. Furthermore, a T
Volume 270,
Number 39,
Issue of September 29, pp. 22988-22996, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
A transversion, that in the HNF-4
binding site of factor IX causes a severe bleeding disorder, was
introduced into the HNF-4-binding site of factor VII and reduced
promoter activity by 20-50%. Coordinate HNF-4-mediated regulation
of several blood protease genes as well as genes involved in lipid
metabolism might account for the positive correlation of these factors
with increased risk of occlusive heart diseases.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. A. Jackson, K. R. Cronin, R. Zachariah, and J. A. Carew CCAAT/Enhancer-binding Protein-beta Participates in Insulin-responsive Expression of the Factor VII Gene J. Biol. Chem., October 26, 2007; 282(43): 31156 - 31165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koizume, M.-S. Jin, E. Miyagi, F. Hirahara, Y. Nakamura, J.-H. Piao, A. Asai, A. Yoshida, E. Tsuchiya, W. Ruf, et al. Activation of Cancer Cell Migration and Invasion by Ectopic Synthesis of Coagulation Factor VII Cancer Res., October 1, 2006; 66(19): 9453 - 9460. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, B. Ho, and J. L. Ding Transcriptional Regulation of Limulus Factor C: REPRESSION OF AN NF{kappa}B MOTIF MODULATES ITS RESPONSIVENESS TO BACTERIAL LIPOPOLYSACCHARIDE J. Biol. Chem., December 5, 2003; 278(49): 49428 - 49437. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ning, S. Lakatoo, M. Liu, W. Yang, Z. Wang, M. J. Phillips, and G. A. Levy Induction of Prothrombinase fgl2 by the Nucleocapsid Protein of Virulent Mouse Hepatitis Virus Is Dependent on Host Hepatic Nuclear Factor-4alpha J. Biol. Chem., April 25, 2003; 278(18): 15541 - 15549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Wilcox, S. Noguchi, and J. Casanova Extrahepatic Synthesis of Factor VII in Human Atherosclerotic Vessels Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 136 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tarumi, D. V. Kravtsov, M. Zhao, S. M. Williams, and D. Gailani Cloning and Characterization of the Human Factor XI Gene Promoter. TRANSCRIPTION FACTOR HEPATOCYTE NUCLEAR FACTOR 4alpha (HNF-4alpha ) IS REQUIRED FOR HEPATOCYTE-SPECIFIC EXPRESSION OF FACTOR XI J. Biol. Chem., May 17, 2002; 277(21): 18510 - 18516. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Di Bitondo, A. J. Hall, I. R. Peake, L. Iacoviello, and P. R. Winship Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region Hum. Mol. Genet., April 1, 2002; 11(7): 723 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang and M. C. Lucy Involvement of Hepatocyte Nuclear Factor-4 in the Expression of the Growth Hormone Receptor 1A Messenger Ribonucleic Acid in Bovine Liver Mol. Endocrinol., June 1, 2001; 15(6): 1023 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Carew, E. S. Pollak, S. Lopaciuk, and K. A. Bauer A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency Blood, December 15, 2000; 96(13): 4370 - 4372. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Desvergne and W. Wahli Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism Endocr. Rev., October 1, 1999; 20(5): 649 - 688. [Abstract] [Full Text] |
||||
![]() |
F. M. van 't Hooft, A. Silveira, P. Tornvall, A. Iliadou, E. Ehrenborg, P. Eriksson, and A. Hamsten Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration Blood, May 15, 1999; 93(10): 3432 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Kapitskaya, N. T. Dittmer, K. W. Deitsch, W.-L. Cho, D. G. Taylor, T. Leff, and A. S. Raikhel Three Isoforms of a Hepatocyte Nuclear Factor-4 Transcription Factor with Tissue- and Stage-specific Expression in the Adult Mosquito J. Biol. Chem., November 6, 1998; 273(45): 29801 - 29810. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Farsetti, F. Moretti, M. Narducci, S. Misiti, S. Nanni, M. Andreoli, A. Sacchi, and A. Pontecorvi Orphan Receptor Hepatocyte Nuclear Factor-4 Antagonizes Estrogen Receptor {alpha}-Mediated Induction of Human Coagulation Factor XII Gene Endocrinology, November 1, 1998; 139(11): 4581 - 4589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Carew, E. S. Pollak, K. A. High, and K. A. Bauer Severe Factor VII Deficiency Due to a Mutation Disrupting an Sp1 Binding Site in the Factor VII Promoter Blood, September 1, 1998; 92(5): 1639 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Stauffer, B. N. Chukwumezie, J. A. Wilberding, E. D. Rosen, and F. J. Castellino Characterization of Transcriptional Regulatory Elements in the Promoter Region of the Murine Blood Coagulation Factor VII Gene J. Biol. Chem., January 23, 1998; 273(4): 2277 - 2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hadzopoulou-Cladaras, E. Kistanova, C. Evagelopoulou, S. Zeng, C. Cladaras, and J. A.A. Ladias Functional Domains of the Nuclear Receptor Hepatocyte Nuclear Factor 4 J. Biol. Chem., January 3, 1997; 272(1): 539 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Arbini, E. S. Pollak, J. K. Bayleran, K. A. High, and K. A. Bauer Severe Factor VII Deficiency Due to a Mutation Disrupting a Hepatocyte Nuclear Factor 4 Binding Site in the Factor VII Promoter Blood, January 1, 1997; 89(1): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cairns, C. A.D. Smith, A. W. McLaren, and C. R. Wolf Characterization of the Human Cytochrome P4502D6 Promoter. A POTENTIAL ROLE FOR ANTAGONISTIC INTERACTIONS BETWEEN MEMBERS OF THE NUCLEAR RECEPTOR FAMILY J. Biol. Chem., October 11, 1996; 271(41): 25269 - 25276. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |